Sure, but the R&D is largely subsidized because it’s a common good. Pharmaceutical companies generally take over when it’s already a pretty safe bet… It could fall through during clinical trials, but they don’t pay for the massive R&D they did traditionally. Sometimes they even just buy the patent

There’s overhead, but the vast majority is just profiteering